ONCY — ONCOLYTICS BIOTECH INC
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-06-01.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ONCY
| date | signal | measured base rate |
|---|---|---|
| 2026-07-07 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-06-01 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-03-12 | Kelly Jared Chief Executive Officer | Open-market purchase | 5.0K | 0.96 | 4.8K |
| 2026-03-11 | Parsons James T. Director | Open-market purchase | 10.0K | 1.03 | 10.3K |
| 2026-02-12 | Seizinger Bernd R. Director | Open-market purchase | 40.0K | 0.85 | 34.0K |
| 2026-02-12 | Andrews Patricia S Director | Open-market purchase | 35.4K | 0.86 | 30.4K |
| 2026-02-12 | Pisano Wayne Director | Open-market purchase | 30.0K | 0.84 | 25.2K |
| 2026-02-12 | Kelly Jared Chief Executive Officer | Open-market purchase | 29.5K | 0.84 | 24.8K |
| 2026-02-12 | Brown Deborah Margaret Director | Open-market purchase | 25.0K | 0.85 | 21.2K |
| 2026-02-12 | Look Kirk Chief Financial Officer | Open-market purchase | 12.0K | 0.84 | 10.1K |
| 2026-02-12 | Heineman Thomas Charles Chief Medical Officer | Open-market purchase | 12.1K | 0.83 | 10.1K |
| 2026-02-12 | Hagerman Allison VP, Product Development | Open-market purchase | 10.0K | 0.83 | 8.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| MARSHALL WACE, LLP | 730.9K | 859.8K |
| RENAISSANCE TECHNOLOGIES LLC | 607.6K | 715.8K |
| Sandbox Financial Partners, LLC | 339.5K | 400.0K |
| SEEDS INVESTOR LLC | 263.5K | 258.3K |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 126.5K | 149.0K |
| Everhart Financial Group, Inc. | 117.3K | 138.2K |
| XTX Topco Ltd | 93.2K | 109.8K |
| DOLIVER ADVISORS, LP | 84.9K | 100.0K |
| FRANKLIN RESOURCES INC | 71.3K | 69.8K |
| LPL Financial LLC | 67.0K | 78.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-18 | 2026-08-18 | on EDGAR ↗ |
| 10-Q | 2026-08-12 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-07-24 | 2026-07-20 | on EDGAR ↗ |
| 8-K | 2026-07-20 | 2026-07-20 | on EDGAR ↗ |
| 8-K | 2026-07-13 | 2026-07-13 | on EDGAR ↗ |
| 8-K | 2026-07-08 | 2026-07-06 | on EDGAR ↗ |
| 8-K | 2026-06-16 | 2026-06-16 | on EDGAR ↗ |
| 3 | 2026-06-03 | 2026-06-01 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Oncolytics Biotech Inc (ONCY) filed form 8-K · 2026-08-18 · SEC EDGAR
- ONCOLYTICS BIOTECH INC (ONCY) filed form 8-K · 2026-08-18 · SEC EDGAR
Ask the AI about ONCY
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →